# reload+after+2024-01-22 08:39:36.286873
address1§2545 West Hillcrest Drive
address2§Suite 140
city§Thousand Oaks
state§CA
zip§91320
country§United States
phone§805 409 9868
website§https://lunglifeai.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. It engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.
fullTimeEmployees§15
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Paul  Pagano Ph.D.', 'age': 39, 'title': 'CEO, Chief Scientific Officer & Executive Director', 'yearBorn': 1984, 'fiscalYear': 2022, 'totalPay': 263432, 'exercisedValue': 0, 'unexercisedValue': 143276}, {'maxAge': 1, 'name': 'Mr. David M. Anderson', 'age': 60, 'title': 'CFO, Company Secretary & Executive Director', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 191921, 'exercisedValue': 0, 'unexercisedValue': 3316}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§-0.116
priceToSalesTrailing12Months§430.50674
currency§GBp
forwardEps§-0.13
exchange§LSE
quoteType§EQUITY
shortName§LUNGLIFE AI, INC ORD USD0.0001 
longName§LungLife AI, Inc.
firstTradeDateEpochUtc§1625727600
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§147d2d33-e390-386c-a374-8fc19d113457
targetHighPrice§2.29
targetLowPrice§2.2
targetMeanPrice§2.25
targetMedianPrice§2.25
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§2
quickRatio§3.888
grossMargins§1.0
ebitdaMargins§0.0
trailingPegRatio§None
